The circadian clock in the suprachiasmatic nucleus (SCN) regulates daily rhythms in physiology and 3 behaviour and is an important part of the mammalian homeostatic system. Previously, we have 4 shown that systemic inflammatory stimulation with lipopolysaccharide (LPS) induced the daytime-5 dependent phosphorylation of STAT3 in the SCN. Here, we demonstrate the LPS-induced Stat3 mRNA 6 expression in the SCN and show also the circadian rhythm in Stat3 expression in the SCN, with high 7 levels during the day. Moreover, we examined the effects of LPS (1mg/kg), applied either during the 8 day or the night, on the rhythm in locomotor activity of male Wistar rats. We observed that recovery 9 of normal locomotor activity patterns took longer when the animals were injected during the night.
Introduction 22
The temporal organisation of behavioural and physiological functions in mammals mostly depends 23 on the timing signals generated by the circadian clock in the suprachiasmatic nucleus (SCN). The SCN 24 integrates external timing cues with an endogenous molecular clockwork and synchronises circadian 25 oscillations in other brain parts and peripheral tissues (Albrecht, 2012) . The morphology of the SCN 3 26 varies across species, but its basic structure is shared by all mammals. It consists of two main parts:
27 the shell or the dorsomedial part (dmSCN), which contains intrinsically rhythmic cells, and the core or 28 the ventrolateral part (vlSCN), which receives most of the regulatory inputs from other parts of the 29 brain (Morin, 2007) . The molecular basis of a circadian clock involves several interlocking 30 transcriptional loops of clock genes, such as Clock, Bmal1, Period 1 (Per1), Per2, Cryptochrome 1 31 (Cry1) and Cry2, Casein kinase 1 epsilon (CK1ε), RevErbα (Nr1d1) and Rorα. The stability of these Locomotor activity measurement 87 The locomotor activity of 20 rats was monitored using infrared motion detectors (Mini-Mitter 88 VitalView data acquisition system) for three days before the experiment, which served as an internal 89 control for total activity, acrophase and amplitude. On the day of the experiment, 10 rats received an 90 intraperitoneal injection of LPS (from E. coli, strain 055:B5; 1 mg/kg; Sigma Aldrich) at ZT6, as did 10 91 rats at ZT15. Activity counts accumulated over a 1-h period were fitted with single cosine curves, as and 5 h (P = 0.0056) after application (Fig. 3A) . In the nightime, the LPS induced the Stat3 mRNA of 210 11 ± 0.86 of the control values in 2 h, and 2.7 ± 0.37 times in 5 h (Fig. 3D ). To verify the results 211 obtained from in situ hybridisation, we checked the day/night difference in LPS effect at one time 212 point using RT-PCR from the SCN isolated by laser dissection (Fig. 3B, C) . Multiple t-tests with the 213 Sidak-Bonferroni method showed that the mRNA level increased significantly after LPS at both ZT6 (P 214 = 0.0091) and ZT15 (P = 0.0096). However, in the daytime, the LPS induced the Stat3 mRNA of only 215 1.417 ± 0.1598 of the control values, but LPS applied at ZT15 increased the Stat3 mRNA 15.8 ± 2.6 216 times (Fig. 3E ). This result thus corresponds with the data obtain by in situ hybridization and confirms 217 that the Stat3 expression would show greater LPS-induced increase during the night apparently due 218 to the low endogenous mRNA level during the night (Fig. 2 ). The significant difference between the 219 day and night control groups (P < 0.0001; Fig. 3B ) confirms the day/night difference of Stat3 220 expression revealed by optic density measurements of in situ autoradiographs (Fig. 2) . 
268
LPS applied at ZT6 did not significantly induce pGSK3β increase in the SCN at any time point, 269 although on average, the level of pGSK3β in all LPS-treated sections was 1.4648 (± 0.1691) higher 270 than the level in control sections (Fig. 5D, E) . LPS applied at ZT15 significantly reduced the number of 271 pGSK3β immunopositive cells in the vlSCN within 8 h (P = 0.0073) (Fig. 5D ). There was no significant 272 change in pGSK3β levels in dmSCN at night (Fig. 5E ). however, only used one daytime period for inflammatory stimulation, although it is well understood 288 that the susceptibility of organisms to inflammatory stimuli is affected by the circadian clock.
289
Previously, we have shown that LPS applied either during the day or at night affects the 290 phosphorylation of STAT3 in the SCN differently (Moravcová et al., 2016) . In this study, we followed 
300
The behavioural effect of the 1 mg/kg LPS dose was controlled using locomotor activity 301 monitoring. The maximal reduction of locomotion was observed the first day after the LPS treatment, 302 as expected, but the gradual recovery process proceeded faster when the animals were infected 14 303 during the day compared with at night. Total activity counts and the amplitude of the behavioural 304 rhythm seemed to return to their original state faster after the daytime LPS injection. Considering 305 the locomotor activity measurement as one of the markers of sickness behaviour, which typically 306 occurs after infection (Hart, 1988) , our observation suggests that the sickness behaviour after the LPS 307 treatment can be improved more quickly if animals are infected during the day. This corresponded 308 well to the organism's reduced reaction to a parasitic infection when the organism was infected 309 during the day compared to at night (Kiessling et al., 2017) . It has been demonstrated that LPS 310 administration at ZT14 triggers higher plasma level of cytokines IL-6 and TNF-α as compared with 311 administration at ZT2, which has been associated with daily changes in SCN activity (Guerrero-Vargas 312 et al., 2014). It may, therefore, be possible that higher levels of inflammatory cytokines at night 313 decelerate the amelioration of sickness or worsen the symptoms.
314
STAT3 plays various roles in many cell types, but it is best known as a regulator of the 315 inflammatory response and of cancer growth (Rummel, 2016; Yu et al., 2014) . In the brain, STAT3 316 plays a significant role in astrocyte reactivity in response to pathological conditions in the nervous 317 tissue (Ceyzériat et al., 2016) . Our data showed that LPS administration at ZT15 induced about 10 318 times higher Stat3 mRNA levels than at ZT6. There was also a significant difference in mRNA levels 319 between day and night among the control animals, so we performed in situ hybridisation to detect 320 the circadian profile of Stat3 expression in the SCN. 
388
It may be important to reiterate that GSK3β kinase is active in its dephosphorylated state. It is, 389 therefore, possible that a short-term increase in its activity contributes to LPS-induced changes in 390 cytokine level at night. In the circadian pacemaker, the transient GSK3β-induced increase of 391 phosphorylation of clock proteins could change the dynamics of the clockwork mechanism and thus 392 participate in maintaining a steady-state clock status.
393
The induction and reduction of the clock genes and pERK1/2 with the pGSK3β levels in the SCN in phase (Osland et al., 2011) . It is possible that the mild processes within the circadian clockwork help 408 to balance the possible dysregulation of the circadian clock output.
409
Conclusions 410
The present study shows that the time of LPS administration affects the recovery rate of locomotor 411 activity rhythm and induces the transient changes in clock gene expression and the levels of pERK1/2 412 and pGSK3β in the rat SCN that may be a part of the steady-state function of the clock in mild 413 pathological conditions. We also provide the first report on the circadian rhythmicity of Stat3 gene 414 expression in the SCN, and we demonstrate that the LPS administration induces not only 415 phosphorylation of STAT3 that has been shown previously, but also its transcription and regulate 416 thus significantly Stat3 mRNA level in the SCN.
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